Stay updated on Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a new revision entry, Revision: v3.4.2, to the study record history. Removed older administrative notices including the government funding lapse alert and the Revision: v3.4.1 entry.SummaryDifference0.6%

- Check22 days agoChange DetectedAdded a government funding notice in the header and updated the revision tag to v3.4.1; the previous tag v3.4.0 was removed.SummaryDifference0.6%

- Check29 days agoChange DetectedUI and formatting updates to the record history page include a glossary toggle, color-coded highlights for additions and deletions, and explicit revision labels. These are presentational changes that do not alter underlying study data or substantive content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check43 days agoChange DetectedAdded Revision: v3.3.4 to the history and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe history page now shows Revision: v3.3.3 and removes the HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page history now shows revision label v3.3.2 replacing v3.3.1, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.